Horwitz DA[au] - Search Results

Year	Number of Results
1970	1
1971	1
1972	4
1973	2
1974	3
1975	3
1976	2
1977	6
1978	3
1979	3
1980	6
1981	1
1982	2
1983	3
1984	5
1985	5
1986	2
1987	4
1988	4
1989	1
1990	2
1991	1
1992	1
1993	1
1994	5
1995	1
1996	1
1997	2
1998	4
1999	5
2001	3
2002	2
2003	1
2004	3
2005	1
2006	4
2007	1
2008	5
2010	5
2012	3
2013	2
2014	3
2015	2
2019	2
2020	1
2021	4
2022	1

1

Rebalancing Immune Homeostasis to Treat Autoimmune Diseases.

Horwitz DA, Fahmy TM, Piccirillo CA, La Cava A. Horwitz DA, et al. Trends Immunol. 2019 Oct;40(10):888-908. doi: 10.1016/j.it.2019.08.003. Epub 2019 Oct 7. Trends Immunol. 2019. PMID: 31601519 Free PMC article. Review.

2

Trauma rehabilitation outcome scoring.

Horwitz DA, Schuerer DJ. Horwitz DA, et al. Curr Opin Crit Care. 2008 Aug;14(4):445-50. doi: 10.1097/MCC.0b013e328307f25f. Curr Opin Crit Care. 2008. PMID: 18614910 Review.

3

Identity of mysterious CD4+CD25-Foxp3+ cells in SLE.

Horwitz DA. Horwitz DA. Arthritis Res Ther. 2010;12(1):101. doi: 10.1186/ar2894. Epub 2010 Jan 20. Arthritis Res Ther. 2010. PMID: 20122288 Free PMC article. Review.

4

Strategies to Use Nanoparticles to Generate CD4 and CD8 Regulatory T Cells for the Treatment of SLE and Other Autoimmune Diseases.

Horwitz DA, Bickerton S, La Cava A. Horwitz DA, et al. Front Immunol. 2021 Jun 15;12:681062. doi: 10.3389/fimmu.2021.681062. eCollection 2021. Front Immunol. 2021. PMID: 34211471 Free PMC article. Review.

5

Peripheral blood CD4+ T cells in systemic lupus erythematosus.

Horwitz DA. Horwitz DA. Lupus. 2001;10(5):319-20. doi: 10.1191/096120301676469109. Lupus. 2001. PMID: 11403261 Review. No abstract available.

6

Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4⁺ and CD8⁺ Tregs That Are Functional in Humanized Mice.

Giang S, Horwitz DA, Bickerton S, La Cava A. Giang S, et al. Among authors: horwitz da. Front Immunol. 2021 May 26;12:628059. doi: 10.3389/fimmu.2021.628059. eCollection 2021. Front Immunol. 2021. PMID: 34122401 Free PMC article.

7

Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin.

Lee JS, Han P, Chaudhury R, Khan S, Bickerton S, McHugh MD, Park HB, Siefert AL, Rea G, Carballido JM, Horwitz DA, Criscione J, Perica K, Samstein R, Ragheb R, Kim D, Fahmy TM. Lee JS, et al. Among authors: horwitz da. Nat Biomed Eng. 2021 Sep;5(9):983-997. doi: 10.1038/s41551-021-00791-0. Epub 2021 Oct 6. Nat Biomed Eng. 2021. PMID: 34616050

8

Regulatory T cells in systemic lupus erythematosus: past, present and future.

Horwitz DA. Horwitz DA. Arthritis Res Ther. 2008;10(6):227. doi: 10.1186/ar2511. Epub 2008 Nov 14. Arthritis Res Ther. 2008. PMID: 19040771 Free PMC article. Review.

9

Editorial: Generating and Sustaining Stable Autoantigen-Specific CD4 and CD8 Regulatory T Cells in Lupus.

Datta SK, Horwitz DA, Piccirillo CA, La Cava A. Datta SK, et al. Among authors: horwitz da. Front Immunol. 2022 Mar 7;13:838604. doi: 10.3389/fimmu.2022.838604. eCollection 2022. Front Immunol. 2022. PMID: 35340806 Free PMC article. No abstract available.

10

Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other.

Horwitz DA, Zheng SG, Gray JD. Horwitz DA, et al. Trends Immunol. 2008 Sep;29(9):429-35. doi: 10.1016/j.it.2008.06.005. Epub 2008 Aug 3. Trends Immunol. 2008. PMID: 18676178 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results